GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 6,480.00
+120.00 (1.89%)
Nov 20, 2025, 3:30 PM KST
GC Genome Revenue
GC Genome had revenue of 7.81B KRW in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 28.70B. In the year 2024, GC Genome had annual revenue of 25.89B, down -5.15%.
Revenue (ttm)
28.70B
Revenue Growth
-5.15%
P/S Ratio
5.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
150.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.89B | -1.40B | -5.15% |
| Dec 31, 2023 | 27.29B | 3.18B | 13.18% |
| Dec 31, 2022 | 24.11B | 5.62B | 30.36% |
| Dec 31, 2021 | 18.50B | 4.94B | 36.46% |
| Dec 31, 2020 | 13.56B | 1.40B | 11.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |